Circular Genomics Receives $250K Investment from the Alzheimer's Drug Discovery Foundation (ADDF) to Advance First-in-Class Circular RNA Blood-Based Biomarker Tests for the Early Detection of AD

Press releases

Jul 8

Circular Genomics Announces Formation of its Commercial Advisory Board with Veteran Industry Leaders

Press releases

Jun 18

Paul Sargeant, PhD, CEO of Circular Genomics Presents at LSI USA '25 - "Circular RNA Biomarkers for Depression Treatment"

News

Apr 22

Circular Genomics Strengthens Scientific Advisory Board with Addition of Alzheimer's Disease Expert

Press releases

Mar 19

Circular Genomics Joins Lilly Gateway Labs in San Diego to Develop Its Best-In-Class Circular RNA Platform for the Diagnosis and Prognosis of Alzheimer's Disease

Press releases

Mar 17

5 Promising RNA Biotech Companies To Watch in 2025

News

Mar 13